# US 5,922,027 A · Articular cartilage heterografts

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 5,922,027 A
- Document ID: US5922027A
- Status: Granted
- Kind: A
- Application number: 08/992,973
- Filed: 1997-12-18
- Granted: 1999-07-13
- Earliest claimed: 1995-09-15
- Assignees: CrossCart, Inc.
- Inventors: Kevin R. Stone
- Web page: https://patentgrep.com/patent/US5922027A

## CPC

- A61L 27/3687: {characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents}
- A61F 2/30756: {Cartilage endoprostheses (A61F2/3603 takes precedence)}
- A61L 2/20: Gaseous substances, e.g. vapours
- A61L 2/204: Formaldehyde
- A61L 2/206: Ethylene oxide
- A61L 27/3608: {Bone, e.g. demineralised bone matrix [DBM], bone powder}
- A61L 27/3612: {Cartilage, synovial fluid}
- A61L 27/3654: {Cartilage, e.g. meniscus}
- A61L 27/3683: {subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61F 2/3094: {Designing or manufacturing processes}
- A61F 2/3859: {Femoral components}
- A61F 2/389: {Tibial components (A61F2/3868 takes precedence)}
- A61L 2430/06: for cartilage reconstruction, e.g. meniscus
- Y10S 623/901: Method of manufacturing prosthetic device
- Y10S 623/915: Method or apparatus for preparing biological material
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

The invention provides an article of manufacture comprising a substantially non-immunogenic articular cartilage heterograft for implantation into humans. The invention further provides a method for preparing an articular cartilage heterograft by removing at least a portion of an articular cartilage from a non-human animal to provide a heterograft; washing the heterograft in saline and alcohol; subjecting the heterograft to at least one treatment selected from the group consisting of exposure to ultraviolet radiation, immersion in alcohol, ozonation, freeze/thaw cycling, and optionally to chemical crosslinking. In accordance with the invention the heterograft has substantially the same mechanical properties as the native xenogeneic articular cartilage.

## Claims

### Claim 1

An article of manufacture comprising a substantially non-immunogenic glycosidase-treated articular cartilage heterograft for implantation into a human; said heterograft having surface carbohydrate moieties removed therefrom; whereby the heterograft has substantially the same mechanical properties as a corresponding portion of a native articular cartilage.

### Claim 2 (depends on 1)

The article of manufacture of claim 1 wherein the heterograft includes a bone layer substrate.

### Claim 3 (depends on 1)

The article of manufacture of claim 1, wherein the heterograft is a processed native xenogeneic articular cartilage.

### Claim 4 (depends on 3)

The article of manufacture of claim 3 wherein the heterograft includes a bone layer substrate.

### Claim 5 (depends on 1)

The article of manufacture of claim 1, wherein the heterograft is a segment of a processed native xenogenic articular cartilage.

### Claim 6 (depends on 5)

The article of manufacture of claim 5 wherein the heterograft includes a bone layer substrate.

### Claim 7

An article of manufacture comprising a substantially non-immunogenic glycosidase-treated articular cartilage heterograft for implantation into a human, produced by the process of
a. removing at least an intact portion of an articular cartilage from a joint of a non-human animal to provide a heterograft;
b. washing the heterograft in water and alcohol; and
c. digesting the heterograft with a glycosidase to remove surface carbohydrate moieties from the heterograft;
whereby the heterograft has substantially the same mechanical properties as a corresponding portion of a native articular cartilage.

### Claim 8 (depends on 7)

The article of manufacture of claim 7, further comprising a bone layer substrate.

### Claim 9 (depends on 7)

The article of manufacture of claim 7 wherein the heterograft has a plurality of punctures for increasing permeability to agents and enzymes.

### Claim 10 (depends on 7)

The article of manufacture of claim 7, further comprising
one or more agents selected from the group consisting of anticalcification agents, antithrombotic agents, antibiotics, and growth factors.

### Claim 11 (depends on 7)

The article of manufacture of claim 7 wherein the heterograft is sterilized.

### Claim 12 (depends on 7)

The article of manufacture of claim 7, wherein the portion is a segment of the articular cartilage.

### Claim 13 (depends on 12)

The article of manufacture of claim 12, further comprising a bone layer substrate.

### Claim 14

An articular cartilage heterograft for implantation into a human comprising
a portion of an articular cartilage from a joint of a non-human animal, wherein the portion has substantially no surface carbohydrate moieties which are susceptible to glycosidase digestion, and
whereby the portion is substantially non-immunogenic and has substantially the same mechanical properties as a corresponding portion of a native articular cartilage.

### Claim 15 (depends on 14)

The articular cartilage heterograft of claim 14, further comprising a bone layer substrate.

### Claim 16 (depends on 14)

The articular cartilage heterograft of claim 14, wherein the portion is a segment of the articular cartilage.

### Claim 17 (depends on 16)

The articular cartilage heterograft of claim 16, further comprising a bone layer substrate.
